Title:

Theranostics for Precision Cancer Diagnosis and Treatment

Speaker:

Dr. Sandra Davern

Affiliation:

Oak Ridge National Laboratory

When:

Thursday, February 13, 2025 at 11:00:00 AM   Add to Calendar

Where:

Boggs Building, Room 3-47

Host:

Chaitanya Deo
cdeo3@gatech.edu

Abstract

The potential of medical radioisotopes as a treatment for metastatic cancer is currently being realized. In addition, the power of molecular imaging to diagnose and identify the best patient populations to treat is vital to advance therapeutic applications. Theranostics has been coined as the term to convey that the same targeting vector is used for both applications. Oak Ridge National Laboratory is one of the leading national laboratories to produce radioisotopes for medical applications and is also engaged in research to advance theranostic applications. This presentation will discuss some of the radioisotope production, and research in this area ongoing at Oak Ridge National Laboratory.

Biography

Sandra Davern leads the Radioisotope Research and Development Section in the Radioisotope Science and Technology Division of the Isotope Science and Engineering Directorate at Oak Ridge National Laboratory. At ORNL, she has worked on and led multiple projects, including establishing quality assurance systems for Ac-227 isotope production, microfluidics for separations chemistry and radiobiology, inkjet printing of thin film actinides, and nano-constructs for radiotherapeutics. She has a degree in Biotechnology from Dublin City University and a PhD in Pharmacology from University College Dublin, Ireland. Her post-doc was at ORNL on Targeted Alpha Therapies using phage display for novel targeting vectors.

Notes

Meet the speaker